The options carry an exercise price of $41.77 per share, matching the closing price of the company's common stock on the Nasdaq Global Select Market on the date of the grant. These awards were structured under the 2023 Employment Inducement Incentive Award Plan, a framework reserved exclusively for new recruits or individuals returning after a substantial period of non-employment.
IDEAYA Biosciences Issues Stock Options to New Hires
South San Francisco-based IDEAYA Biosciences has issued non-qualified stock options for 62,800 shares to two incoming employees. The move, finalized by the company’s Compensation Committee on August 27, serves as a material inducement for these individuals to join the precision medicine oncology firm under Nasdaq regulatory guidelines.
Regarding the payout structure, the options feature a 10-year term with a four-year vesting schedule. One-quarter of the total grant vests on the first anniversary of the commencement date, while the remaining balance vests in equal monthly installments over the following three years. Continued service remains a mandatory requirement for all vesting milestones.
Comments (0)
No comments yet. Be the first!